Cutera (CUTR) 10-Q 2 May 16 2016 Q1 Quarterly report Financial data

Document And Entity Information

Document And Entity Information - shares	3 Months Ended
	Mar. 31, 2016	Apr. 30, 2016
Entity Registrant Name	CUTERA INC
Entity Central Index Key	1,162,461
Trading Symbol	cutr
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Current Reporting Status	Yes
Entity Voluntary Filers	No
Entity Well-known Seasoned Issuer	No
Entity Common Stock, Shares Outstanding (in shares)		13,081,930
Document Type	10-Q
Document Period End Date	Mar. 31, 2016
Document Fiscal Year Focus	2,016
Document Fiscal Period Focus	Q1
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheet (Current Period Unaudited) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Convertible Preferred Stock [Member]
Stockholders’ equity:
Convertible preferred stock, $0.001 par value; authorized: 5,000,000 shares; none issued and outstanding
Cash and cash equivalents	$ 6,265	$ 10,868
Marketable investments	38,184	37,539
Accounts receivable, net	11,168	11,669
Inventories	13,475	12,078
Other current assets and prepaid expenses	1,953	1,675
Total current assets	71,045	73,829
Property and equipment, net	1,428	1,473
Deferred tax asset	376	350
Intangibles, net	87	143
Goodwill	1,339	1,339
Other long-term assets	419	384
Total assets	74,694	77,518
Accounts payable	2,570	1,959
Accrued liabilities	11,079	13,834
Deferred revenue	8,836	8,638
Total current liabilities	22,485	24,431
Deferred revenue, net of current portion	1,986	2,287
Income tax liability	127	182
Other long-term liabilities	507	584
Total liabilities	$ 25,105	$ 27,484
Commitments and Contingencies (Note 10)
Common stock, $0.001 par value; authorized: 50,000,000 shares; issued and outstanding: 13,076,642 and 12,980,807 shares at March 31, 2016 and December 31, 2015, respectively	$ 13	$ 13
Additional paid-in capital	81,319	79,782
Accumulated deficit	(31,723)	(29,672)
Accumulated other comprehensive loss	(20)	(89)
Total stockholders’ equity	49,589	50,034
Total liabilities and stockholders’ equity	$ 74,694	$ 77,518

Condensed Consolidated Balance3

Condensed Consolidated Balance Sheet (Current Period Unaudited) (Parentheticals) - $ / shares	Mar. 31, 2016	Dec. 31, 2015
Convertible Preferred Stock [Member]
Convertible preferred stock, par value (in dollars per share)	$ 0.001	$ 0.001
Convertible preferred stock, authorized (in shares)	5,000,000	5,000,000
Convertible preferred stock, issued (in shares)	0	0
Convertible preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, authorized (in shares)	50,000,000	50,000,000
Common stock, issued (in shares)	13,076,642	12,980,807
Common stock, outstanding (in shares)	13,076,642	12,980,807

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations (Unaudited) - USD ($) shares in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net revenue:
Products	$ 17,956,000	$ 14,703,000
Service	4,467,000	4,368,000
Total net revenue	22,423,000	19,071,000
Cost of revenue:
Products	7,648,000	7,309,000
Service	2,301,000	1,743,000
Total cost of revenue	9,949,000	9,052,000
Gross profit	12,474,000	10,019,000
Operating expenses:
Sales and marketing	8,716,000	8,187,000
Research and development	2,709,000	2,445,000
General and administrative	3,220,000	2,989,000
Total operating expenses	14,645,000	13,621,000
Loss from operations	(2,171,000)	(3,602,000)
Interest and other income, net	144,000	8,000
Loss before income taxes	(2,027,000)	(3,594,000)
Provision for income taxes	24,000	50,000
Net loss	$ (2,051,000)	$ (3,644,000)
Net loss per share:
Basic and Diluted (in dollars per share)	$ (0.16)	$ (0.25)
Weighted-average number of shares used in per share calculations:
Basic and Diluted (in shares)	13,010	14,611

Condensed Consolidated Stateme5

Condensed Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Net loss	$ (2,051)	$ (3,644)
Available-for-sale investments
Net change in unrealized gain (loss) on available-for-sale investments	$ 69	$ 33
Less: Reclassification adjustment for gains on investments recognized during the period
Net change in unrealized gain (loss) on available-for-sale investments	$ 69	$ 33
Tax benefit		12
Other comprehensive gain, net of tax	$ 69	21
Comprehensive loss	$ (1,982)	$ (3,623)

Condensed Consolidated Stateme6

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cash flows from operating activities:
Net loss	$ (2,051)	$ (3,644)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock-based compensation	1,332	961
Depreciation and amortization	240	327
Other	12	106
Changes in assets and liabilities:
Accounts receivable	472	737
Inventories	(1,397)	(867)
Other current assets and prepaid expenses	(230)	(15)
Other long-term assets	(35)	(1)
Accounts payable	611	(228)
Accrued liabilities	(2,758)	(2,781)
Other long-term liabilities	(82)	(72)
Deferred revenue	(103)	(559)
Income tax liability	(55)	22
Net cash used in operating activities	(4,044)	(6,014)
Cash flows from investing activities:
Acquisition of property, equipment and software	(97)	(407)
Proceeds from sales of marketable investments	1,800	5,376
Proceeds from maturities of marketable investments	3,975	12,180
Purchase of marketable investments	(6,399)	(8,867)
Net cash provided by (used in) investing activities	(721)	8,282
Cash flows from financing activities:
Repurchase of common stock	(279)	(4,550)
Proceeds from exercise of stock options and employee stock purchase plan	511	6,002
Payments on capital lease obligations	(70)	(61)
Net cash provided by financing activities	162	1,391
Net increase (decrease) in cash and cash equivalents	(4,603)	3,659
Cash and cash equivalents at beginning of period	10,868	9,803
Cash and cash equivalents at end of period	6,265	13,462
Supplemental disclosure of non-cash items:
Repurchase of common stock acquired but not settled	27	$ 656
Assets acquired under capital lease	$ 51

Note 1 - Summary of Significant

Note 1 - Summary of Significant Accounting Policies	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Organization, Consolidation, Basis of Presentation, Business Description and Accounting Policies [Text Block]	Note 1. Summary of Significant Accounting Policies Description of Operations and Principles of Consolidation Cutera, Inc. (“Cutera” or the “Company”) is a global provider of laser and other energy-based aesthetic systems for practitioners worldwide. The Company designs, develops, manufactures, and markets laser and other energy-based product platforms for use by physicians and other qualified practitioners which enable them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following key system platforms: en lighten TM , excel HR TM , truSculpt TM , excel V TM , and xeo ® . Titan ® truSculpt Titan truSculpt Headquartered in Brisbane, California, the Company has wholly-owned subsidiaries that are currently operational in Australia, Belgium, Canada, France, Hong Kong, Japan , Spain , Switzerland and the United Kingdom. These subsidiaries market, sell and service the Company’s products outside of the United States. The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated. Unaudited Interim Financial Information The interim financial information filed is unaudited. The Condensed Consolidated Financial Statements included in this report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for the fair statement of the results of operations for the interim periods covered and of the financial condition of the Company at the date of the interim balance sheet. The December 31, 2015 Condensed Consolidated Balance Sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (“GAAP”). The results for interim periods are not necessarily indicative of the results for the entire year or any other interim period. The Condensed Consolidated Financial Statements should be read in conjunction with the Company’s previously filed audited financial statements and the notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2015 filed with the Securities and Exchange Commission (the “SEC”) on March 15, 2016. Use of Estimates The preparation of interim Condensed Consolidated Financial Statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported and disclosed in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates these estimates, including those related to revenue elements, warranty obligations, sales commissions, accounts receivable and sales allowances, provision for excess and obsolete inventories, fair values of marketable investments, fair values of acquired intangible assets, useful lives of intangible assets and property and equipment, fair values of performance stock units and options to purchase the Company’s stock, recoverability of deferred tax assets, legal matters and claims, and effective income tax rates, among others. Management bases these estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Recent Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, Improvements to Employee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases

Note 2 - Cash, Cash Equivalents

Note 2 - Cash, Cash Equivalents and Marketable Investments	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Cash, Cash Equivalents, and Marketable Securities [Text Block]	Note 2. Cash , Cash Equivalents and Marketable Investments The Company invests its cash primarily in money market funds, commercial paper, corporate notes and bonds, municipal bonds, and debt securities issued by the U.S. government and its agencies. The Company considers all highly liquid investments, with an original maturity of three months or less at the time of purchase, to be cash equivalents. Investments with maturities of greater than three months at the time of purchase are accounted for as “available-for-sale ,” are carried at fair value with unrealized gains and losses reported as a component of stockholders’ equity, are held for use in current operations and are classified in current assets as “marketable investments .” The following tables summarize the components, and the unrealized gains and losses position, related to the Company’s cash, cash equivalents and marketable investments (in thousands): March 31, 2016 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Market Value Cash and cash equivalents: Cash $ 4,734 $ — $ — $ 4,734 Money market funds 1,531 — — 1,531 Commercial paper — — — — Total cash and cash equivalents 6,265 — — 6,265 Marketable investments: U.S. government notes 10,400 18 — 10,418 U.S. government agencies 10,626 3 (5 ) 10,624 Municipal securities 3,764 6 — 3,770 Commercial paper 2,693 2 — 2,695 Corporate debt securities 10,671 9 (3 ) 10,677 Total marketable investments 38,154 38 (8 ) 38,184 Total cash, cash equivalents and marketable investments $ 44,419 $ 38 $ (8 ) $ 44,449 December 31, 2015 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Market Value Cash and cash equivalents: Cash $ 9,830 $ — $ — $ 9,830 Money market funds 1,000 — — 1,000 Commercial paper 38 — — 38 Total cash and cash equivalents 10,868 — — 10,868 Marketable investments: U.S. government notes 7,780 1 (2 ) 7,779 U.S. government agencies 12,630 3 (25 ) 12,608 Municipal securities 4,344 2 — 4,346 Commercial paper 4,041 1 (2 ) 4,040 Corporate debt securities 8,783 — (17 ) 8,766 Total marketable investments 37,578 7 (46 ) 37,539 Total cash, cash equivalents and marketable investments $ 48,446 $ 7 $ (46 ) $ 48,407 As of March 31, 2016 and December 31, 2015, total gross unrealized losses were $8 ,000 and $46,000, respectively, and were related to interest rate changes on available-for-sale marketable investments. The Company has concluded that it is more-likely-than-not that the securities will be held until maturity or the recovery of their cost basis. No securities were in an unrealized loss position for more than 12 months . The following table summarizes the contractual maturities of the Company’s available-for-sale securities, classified as marketable investments as of March 31, 2016 (in thousands): Amount Due in less than one year $ 29,795 Due in 1 to 3 years 8,389 Total marketable investments $ 38,184

Note 3 - Fair Value of Financia

Note 3 - Fair Value of Financial Instruments	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Fair Value Disclosures [Text Block]	Note 3. Fair Value of Financial Instruments Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value hierarchy distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) unobservable inputs (Level 1) (Level 3). ● Level 1: ● Level 2: ● Level 3: In determining fair value, the Company utilizes valuation techniques that maximize the use of observable inputs and minimize the use of unobservable inputs to the extent possible as well as considers counterparty credit risk in its assessment of fair value. As of March 31, 2016, financial assets measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above were as follows (in thousands): March 31, 2016 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 1,531 $ — $ — $ 1,531 Commercial paper — — — — Marketable investments: Available-for-sale securities — 38,184 — 38,184 Total assets at fair value $ 1,531 $ 38,184 $ — $ 39,715 As of December 31, 2015, financial assets measured and recognized at fair value on a recurring basis and classified under the appropriate level of the fair value hierarchy as described above was as follows (in thousands): December 31, 2015 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 1,000 $ — $ — $ 1,000 Commercial paper — 38 — 38 Marketable investments: Available-for-sale securities — 37,539 — 37,539 Total assets at fair value $ 1,000 $ 37,577 $ — $ 38,577 The Company’s Level 2 investments include U.S. government-backed securities and corporate securities that are valued based upon observable inputs that may include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data including market research publications. The average remaining maturity of the Company’s Level 2 investments as of March 31, 2016 is less than 36 months and all of these investments are rated by S&P and Moody’s at A or better .

Note 4 - Balance Sheet Detail

Note 4 - Balance Sheet Detail	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Supplemental Balance Sheet Disclosures [Text Block]	Note 4. Inventories As of March 31, 2016 and December 31, 2015, inventories consist of the following (in thousands): March 3 1 , 201 6 December 31, 201 5 Raw materials $ 8,635 $ 7,982 Finished goods 4,840 4,096 Total $ 13,475 $ 12,078

Note 5 - Warranty

Note 5 - Warranty	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Product Warranty Disclosure [Text Block]	Note 5. Warranty The Company provides a standard one-year warranty on all systems. For direct sales to end customers, warranty coverage provided is for labor and parts necessary to repair the systems during the warranty period. For sales to distributors, we provide a 14-month warranty for parts only. The distributor provides the labor to their end customer. The Company has a direct field service organization in the U.S. Internationally, the Company provides direct service support through its wholly-owned subsidiaries in Australia, Belgium, Canada, France Hong Kong, Spain, Japan , Switzerland and the United Kingdom. In several other countries where it does not have a direct presence, the Company provides service through a network of distributors and third-party service providers. After the original warranty period, maintenance and support are offered on a service contract basis or on a time and materials basis. The Company currently provides for the estimated cost to repair or replace products under warranty at the time of sale. The following table provides the changes in the product warranty accrual for the three months ended March 31, 2016 and 2015 (in thousands): Three Months Ended March 31, 2016 2015 Beginning Balance $ 1,819 $ 1,167 Add: Accruals for warranties issued during the period 1,254 816 Less: Settlements made during the period (1,254 ) (780 ) Ending Balance $ 1,819 $ 1,203

Note 6 - Deferred Service Contr

Note 6 - Deferred Service Contract Revenue	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Deferred Revenue Disclosure [Text Block]	Note 6. Deferred Service Contract Revenue The Company generates Service revenue from the sale of extended service contracts and from time and material services provided to customers who are not under a warranty or extended service contract. Service contract revenue is recognized on a straight-line basis over the period of the applicable contract. Service revenue, from customers whose systems are not under a service contract, is recognized as the services are provided. The following table provides changes in the deferred service contract revenue balance for the three months ended March 31, 2016 and 2015 (in thousands): Three Months Ended March 3 1 , 201 6 201 5 Beginning Balance $ 10,469 $ 12,949 Add: Payments received 3,263 2,802 Less: Revenue recognized (3,220 ) (3,223 ) Ending Balance $ 10,512 $ 12,528 Costs for extended service contracts were $1.6 million and $1.7 million for the three months ended March 31, 2016 and 2015, respectively.

Note 7 - Stockholders' Equity,

Note 7 - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]	Note 7. Stockholders’ Equity and Stock-based Compensation Expense Share Repurchase Program On February 8, 2016, the Company announced that its Board of Directors approved the expansion of its Stock Repurchase Program by $10 million, under which the Company is authorized to repurchase shares of its common stock. In the three months ended March 31, 2016, the Company repurchased 28,013 shares of its common stock for approximately $305,000 . As of March 31, 2016, there remained an additional $9.7 million available in the Stock Repurchase Program to repurchase shares of common stock. All shares repurchased were retired and returned to authorized but unissued status. Stock-based Compensation Expense Stock-based compensation expense by department recognized during the three months ended March 31, 2016 and 2015 were as follows (in thousands): Three Months Ended March 31, 2016 2015 Cost of revenue $ 141 $ 103 Sales and marketing 376 185 Research and development 180 182 General and administrative 635 491 Total stock-based compensation expense $ 1,332 $ 961 Activity under the Company’s 2004 Equity Incentive Plan, as amended, is summarized as follows: Options Outstanding Shares Available for Grant Number of Stock Options Outstanding Weighted- Average Exercise Price Balance, December 31, 2015 1,263,425 2,148,797 $ 9.31 Options granted (28,000 ) 28,000 11.24 Stock awards granted (1)(2) (836,128 ) — — Options exercised — (88,170 ) 8.44 Options canceled 26,213 (26,213 ) 10.21 Stock awards canceled (1) 70,278 — — Balance, March 31, 2016 495,788 2,062,414 $ 9.36 (1) The Company has a “fungible share” provision in its 2004 Equity Incentive Plan whereby for each full-value award (RSU/PSU) issued or canceled under the Plan, results in a requirement to subtract / add back 2.12 shares from / to the Shares Available for Grant. (2) Included in 'Stock awards granted' of 836,128 , was 416,474 fungible shares relating to 196,450 of PSUs granted. These PSUs will result in a higher or lower number of shares of common stock that may be paid out on March 15, 201 7 , based on the achievement of three performance goals at targets that were pre-determined by the Board and disclosed in a Form 8-K on February 8 , 201 6 . Under the 2004 Equity Incentive Plan, as amended, the Company issued 144,312 shares of common stock during the three months ended March 31, 2016 , in conjunction with stock options exercised and the vesting of RSUs and PSUs . As of March 31, 2016, there was approximately $6.6 million of unrecognized compensation expense, net of projected forfeitures , related to non-vested equity awards. The expense is expected to be recognized over the remaining weighted-average period of 2.05 years. The actual expense recorded in the future may be higher or lower based on a number of factors, including, actual forfeitures experienced and the degree of achievement of the performance goals related to the PSUs granted.

Note 8 - Net Loss Per Share

Note 8 - Net Loss Per Share	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Earnings Per Share [Text Block]	Note 8. Net Loss Per Share Basic net loss per share is calculated by dividing net loss by the weighted-average number of common shares outstanding during the year. Diluted net loss per common share is the same as basic net loss per common share, as the effect of the potential common stock equivalents is anti-dilutive and as such is excluded from the calculations of the diluted net loss per share. The following numbers of shares outstanding, prior to the application of the treasury stock method, were excluded from the computation of diluted net loss per common share for the periods presented because including them would have had an anti-dilutive effect (in thousands): Three Months Ended March 3 1 , 201 6 201 5 Options to purchase common stock 3,191 3,164 Restricted stock units 405 318 Performance stock units 158 62 Employee stock purchase plan shares 42 33 Total 3,796 3,577

Note 9 - Income Taxes

Note 9 - Income Taxes	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Income Tax Disclosure [Text Block]	Note 9. Income Taxes The Company’s quarterly income taxes reflect an estimate of the corresponding year’s annual effective tax rate and include, when applicable, adjustments from discrete tax items. The Company’s income tax provision for the three months ended March 31, 2016 and 2015 relates primarily to income taxes of the Company’s non-U.S. operations. The Company’s U.S. operation continue to be in a loss position and the Company maintains a 100% valuation allowance against its U.S. deferred tax assets. For the three months ended March 31, 2016, the Company’s income tax provision declined to $24,000, compared to $50,000 in the same period in 2015, due primarily to certain tax benefits recorded discretely in the quarter. The Company utilizes the asset and liability method of accounting for income taxes, under which deferred taxes are determined based on the temporary differences between the financial statement and tax basis of assets and liabilities using enacted tax rates expected to be in effect during the years in which the basis differences reverse. A valuation allowance is recorded when it is more likely than not that some of the deferred tax assets will not be realized. As of March 31, 2016, the Company had a 100% valuation allowance against its U.S. deferred tax assets. Significant management judgment is required in determining any valuation allowance recorded against deferred tax assets. In evaluating the ability to recover deferred tax assets, the Company considered available positive and negative evidence giving greater weight to its recent cumulative losses and lesser weight to its projected financial results due to the subjectivity involved in forecasting future periods. The Company also considered, commensurate with its objective verifiability, the forecast of future taxable income including the reversal of temporary differences and the implementation of feasible and prudent tax planning strategies.

Note 10 - Commitments and Conti

Note 10 - Commitments and Contingencies	3 Months Ended
	Mar. 31, 2016
Notes to Financial Statements
Commitments and Contingencies Disclosure [Text Block]	Note 10. Commitments and Contingencies Litigation and Litigation Settlements On February 11, 2016, Kendall Jenner and Kendall Jenner Inc. (“Plaintiffs”), filed a lawsuit against the Company in the U.S. District Court, Central District of California, alleging trademark infringement, false endorsement and violation of Jenner’s right of publicity. The claims arise out of alleged advertising referring to news articles describing Jenner’s blog posting regarding her use of Cutera’s Laser Genesis treatment for her acne. In their complaint, the Plaintiffs state that they are seeking “at least $10 million” in compensatory damages and reasonable costs and attorney’s fees. The Company is presently investigating the basis for the claims made, believes it has meritorious defenses to them and intends to defend the matter vigorously. While the Company retains general liability insurance, the insurer is currently denying coverage for this claim. The potential outcome of this litigation cannot be predicted, and the amount of potential damages in the event of an adverse result is not reasonably estimable at this time. The Company is named from time to time as a party to product liability, contractual lawsuits and other general corporate matters in the normal course of business. The Company routinely assesses the likelihood of any adverse judgments or outcomes related to legal matters and claims, as well as ranges of probable losses. A determination of the amount of the reserves required, if any, for these contingencies is made after analysis of each known issue, historical experience, whether it is more likely than not that the Company shall incur a loss, and whether the loss is estimable. As of March 31, 2016 and December 31, 2015, the Company had an immaterial accrual for legal matters and claims and did not expect to incur any material costs beyond the amounts accrued.

Significant Accounting Policies

Significant Accounting Policies (Policies)	3 Months Ended
	Mar. 31, 2016
Accounting Policies [Abstract]
Consolidation, Subsidiaries or Other Investments, Consolidated Entities, Policy [Policy Text Block]	Description of Operations and Principles of Consolidation Cutera, Inc. (“Cutera” or the “Company”) is a global provider of laser and other energy-based aesthetic systems for practitioners worldwide. The Company designs, develops, manufactures, and markets laser and other energy-based product platforms for use by physicians and other qualified practitioners which enable them to offer safe and effective aesthetic treatments to their customers. The Company currently markets the following key system platforms: en lighten TM , excel HR TM , truSculpt TM , excel V TM , and xeo ® . Titan ® truSculpt Titan truSculpt Headquartered in Brisbane, California, the Company has wholly-owned subsidiaries that are currently operational in Australia, Belgium, Canada, France, Hong Kong, Japan , Spain , Switzerland and the United Kingdom. These subsidiaries market, sell and service the Company’s products outside of the United States. The Condensed Consolidated Financial Statements include the accounts of the Company and its subsidiaries. All inter-company transactions and balances have been eliminated.
Unaudited Interim Financial Information [Policy Text Block]	Unaudited Interim Financial Information The interim financial information filed is unaudited. The Condensed Consolidated Financial Statements included in this report reflect all adjustments (consisting only of normal recurring adjustments) that the Company considers necessary for the fair statement of the results of operations for the interim periods covered and of the financial condition of the Company at the date of the interim balance sheet. The December 31, 2015 Condensed Consolidated Balance Sheet was derived from audited financial statements, but does not include all disclosures required by generally accepted accounting principles in the United States of America (“GAAP”). The results for interim periods are not necessarily indicative of the results for the entire year or any other interim period. The Condensed Consolidated Financial Statements should be read in conjunction with the Company’s previously filed audited financial statements and the notes thereto included in the Company’s annual report on Form 10-K for the year ended December 31, 2015 filed with the Securities and Exchange Commission (the “SEC”) on March 15, 2016.
Use of Estimates, Policy [Policy Text Block]	Use of Estimates The preparation of interim Condensed Consolidated Financial Statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported and disclosed in the Condensed Consolidated Financial Statements and the accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company evaluates these estimates, including those related to revenue elements, warranty obligations, sales commissions, accounts receivable and sales allowances, provision for excess and obsolete inventories, fair values of marketable investments, fair values of acquired intangible assets, useful lives of intangible assets and property and equipment, fair values of performance stock units and options to purchase the Company’s stock, recoverability of deferred tax assets, legal matters and claims, and effective income tax rates, among others. Management bases these estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.
New Accounting Pronouncements, Policy [Policy Text Block]	Recent Accounting Pronouncements In March 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-09, Improvements to Employee Share-Based Payment Accounting In February 2016, the FASB issued ASU 2016-02, Leases

Note 2 - Cash, Cash Equivalen18

Note 2 - Cash, Cash Equivalents and Marketable Investments (Tables)	3 Months Ended
	Mar. 31, 2016
Notes Tables
Unrealized Gain (Loss) on Investments [Table Text Block]	March 31, 2016 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Market Value Cash and cash equivalents: Cash $ 4,734 $ — $ — $ 4,734 Money market funds 1,531 — — 1,531 Commercial paper — — — — Total cash and cash equivalents 6,265 — — 6,265 Marketable investments: U.S. government notes 10,400 18 — 10,418 U.S. government agencies 10,626 3 (5 ) 10,624 Municipal securities 3,764 6 — 3,770 Commercial paper 2,693 2 — 2,695 Corporate debt securities 10,671 9 (3 ) 10,677 Total marketable investments 38,154 38 (8 ) 38,184 Total cash, cash equivalents and marketable investments $ 44,419 $ 38 $ (8 ) $ 44,449 December 31, 2015 Amortized Cost Gross Unrealized Gains Gross Unrealized Losses Fair Market Value Cash and cash equivalents: Cash $ 9,830 $ — $ — $ 9,830 Money market funds 1,000 — — 1,000 Commercial paper 38 — — 38 Total cash and cash equivalents 10,868 — — 10,868 Marketable investments: U.S. government notes 7,780 1 (2 ) 7,779 U.S. government agencies 12,630 3 (25 ) 12,608 Municipal securities 4,344 2 — 4,346 Commercial paper 4,041 1 (2 ) 4,040 Corporate debt securities 8,783 — (17 ) 8,766 Total marketable investments 37,578 7 (46 ) 37,539 Total cash, cash equivalents and marketable investments $ 48,446 $ 7 $ (46 ) $ 48,407
Investments Classified by Contractual Maturity Date [Table Text Block]	Amount Due in less than one year $ 29,795 Due in 1 to 3 years 8,389 Total marketable investments $ 38,184

Note 3 - Fair Value of Financ19

Note 3 - Fair Value of Financial Instruments (Tables)	3 Months Ended
	Mar. 31, 2016
Notes Tables
Fair Value Measurements, Recurring and Nonrecurring [Table Text Block]	March 31, 2016 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 1,531 $ — $ — $ 1,531 Commercial paper — — — — Marketable investments: Available-for-sale securities — 38,184 — 38,184 Total assets at fair value $ 1,531 $ 38,184 $ — $ 39,715 December 31, 2015 Level 1 Level 2 Level 3 Total Cash equivalents: Money market funds $ 1,000 $ — $ — $ 1,000 Commercial paper — 38 — 38 Marketable investments: Available-for-sale securities — 37,539 — 37,539 Total assets at fair value $ 1,000 $ 37,577 $ — $ 38,577

Note 4 - Balance Sheet Detail (

Note 4 - Balance Sheet Detail (Tables)	3 Months Ended
	Mar. 31, 2016
Notes Tables
Schedule of Inventory, Current [Table Text Block]	March 3 1 , 201 6 December 31, 201 5 Raw materials $ 8,635 $ 7,982 Finished goods 4,840 4,096 Total $ 13,475 $ 12,078

Note 5 - Warranty (Tables)

Note 5 - Warranty (Tables)	3 Months Ended
	Mar. 31, 2016
Notes Tables
Schedule of Product Warranty Liability [Table Text Block]	Three Months Ended March 31, 2016 2015 Beginning Balance $ 1,819 $ 1,167 Add: Accruals for warranties issued during the period 1,254 816 Less: Settlements made during the period (1,254 ) (780 ) Ending Balance $ 1,819 $ 1,203

Note 6 - Deferred Service Con22

Note 6 - Deferred Service Contract Revenue (Tables)	3 Months Ended
	Mar. 31, 2016
Notes Tables
Deferred Revenue, by Arrangement, Disclosure [Table Text Block]	Three Months Ended March 3 1 , 201 6 201 5 Beginning Balance $ 10,469 $ 12,949 Add: Payments received 3,263 2,802 Less: Revenue recognized (3,220 ) (3,223 ) Ending Balance $ 10,512 $ 12,528

Note 7 - Stockholders' Equity23

Note 7 - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Tables)	3 Months Ended
	Mar. 31, 2016
Notes Tables
Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Table Text Block]	Three Months Ended March 31, 2016 2015 Cost of revenue $ 141 $ 103 Sales and marketing 376 185 Research and development 180 182 General and administrative 635 491 Total stock-based compensation expense $ 1,332 $ 961
Schedule of Share-based Compensation, Activity [Table Text Block]	Options Outstanding Shares Available for Grant Number of Stock Options Outstanding Weighted- Average Exercise Price Balance, December 31, 2015 1,263,425 2,148,797 $ 9.31 Options granted (28,000 ) 28,000 11.24 Stock awards granted (1)(2) (836,128 ) — — Options exercised — (88,170 ) 8.44 Options canceled 26,213 (26,213 ) 10.21 Stock awards canceled (1) 70,278 — — Balance, March 31, 2016 495,788 2,062,414 $ 9.36

Note 8 - Net Loss Per Share (Ta

Note 8 - Net Loss Per Share (Tables)	3 Months Ended
	Mar. 31, 2016
Notes Tables
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]	Three Months Ended March 3 1 , 201 6 201 5 Options to purchase common stock 3,191 3,164 Restricted stock units 405 318 Performance stock units 158 62 Employee stock purchase plan shares 42 33 Total 3,796 3,577

Note 2 - Cash, Cash Equivalen25

Note 2 - Cash, Cash Equivalents and Marketable Investments (Details Textual) - USD ($)	Mar. 31, 2016	Dec. 31, 2015
Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax	$ 8,000	$ 46,000
Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss	$ 0

Note 2 - Unrealized Gains and L

Note 2 - Unrealized Gains and Losses Related to Marketable Investments (Details) - USD ($)	Mar. 31, 2016	Dec. 31, 2015	Mar. 31, 2015	Dec. 31, 2014
Marketable Investments [Member] | Cash [Member]
Amortized Cost	$ 4,734,000
Cash [Member]
Amortized Cost		$ 9,830,000
Fair Market Value	4,734,000	9,830,000
Money Market Funds [Member]
Amortized Cost	1,531,000	1,000,000
Fair Market Value	$ 1,531,000	1,000,000
Commercial Paper [Member]
Amortized Cost		38,000
Fair Market Value		38,000
US Treasury and Government [Member]
Amortized Cost	$ 10,400,000	7,780,000
Gross Unrealized Gains	$ 18,000	1,000
Gross Unrealized Losses		(2,000)
Fair Market Value	$ 10,418,000	7,779,000
US Government Agencies Debt Securities [Member]
Amortized Cost	10,626,000	12,630,000
Gross Unrealized Gains	3,000	3,000
Gross Unrealized Losses	(5,000)	(25,000)
Fair Market Value	10,624,000	12,608,000
US States and Political Subdivisions Debt Securities [Member]
Amortized Cost	3,764,000	4,344,000
Gross Unrealized Gains	$ 6,000	$ 2,000
Gross Unrealized Losses
Fair Market Value	$ 3,770,000	$ 4,346,000
Commercial Paper, Not Included with Cash and Cash Equivalents [Member]
Amortized Cost	2,693,000	4,041,000
Gross Unrealized Gains	$ 2,000	1,000
Gross Unrealized Losses		(2,000)
Fair Market Value	$ 2,695,000	4,040,000
Corporate Debt Securities [Member]
Amortized Cost	10,671,000	$ 8,783,000
Gross Unrealized Gains	9,000
Gross Unrealized Losses	(3,000)	$ (17,000)
Fair Market Value	10,677,000	8,766,000
Amortized Cost	6,265,000	10,868,000	$ 13,462,000	$ 9,803,000
Fair Market Value	6,265,000	10,868,000
Amortized Cost	38,154,000	37,578,000
Gross Unrealized Gains	38,000	7,000
Gross Unrealized Losses	(8,000)	(46,000)
Fair Market Value	38,184,000	37,539,000
Amortized Cost	44,419,000	48,446,000
Fair Market Value	$ 44,449,000	$ 48,407,000

Note 2 - Maturities of Availabl

Note 2 - Maturities of Available-for-Sale Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Due in less than one year	$ 29,795
Due in 1 to 3 years	8,389
Total marketable investments	$ 38,184	$ 37,539

Note 3 - Fair Value of Financ28

Note 3 - Fair Value of Financial Instruments (Details Textual)	3 Months Ended
	Mar. 31, 2016
Maximum Maturity Period Of Investments	3 years

Note 3 - Fair Value of Financ29

Note 3 - Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Fair Value, Measurements, Recurring [Member] | Money Market Funds [Member] | Fair Value, Inputs, Level 1 [Member]
Cash equivalents:
Cash Equivalents	$ 1,531	$ 1,000
Fair Value, Measurements, Recurring [Member] | Money Market Funds [Member]
Cash equivalents:
Cash Equivalents	$ 1,531	1,000
Fair Value, Measurements, Recurring [Member] | Commercial Paper [Member] | Fair Value, Inputs, Level 2 [Member]
Cash equivalents:
Cash Equivalents		38
Fair Value, Measurements, Recurring [Member] | Commercial Paper [Member]
Cash equivalents:
Cash Equivalents		38
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]
Marketable investments:
Total assets at fair value	$ 1,531	1,000
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]
Marketable investments:
Available-for-sale securities	38,184	37,539
Total assets at fair value	38,184	$ 37,577
Fair Value, Measurements, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]
Marketable investments:
Total assets at fair value
Fair Value, Measurements, Recurring [Member]
Marketable investments:
Available-for-sale securities	38,184	$ 37,539
Total assets at fair value	39,715	38,577
Money Market Funds [Member]
Cash equivalents:
Cash Equivalents	$ 1,531	1,000
Commercial Paper [Member]
Cash equivalents:
Cash Equivalents		38
Cash Equivalents	$ 6,265	10,868
Marketable investments:
Available-for-sale securities	$ 38,184	$ 37,539

Note 4 - Inventories (Details)

Note 4 - Inventories (Details) - USD ($) $ in Thousands	Mar. 31, 2016	Dec. 31, 2015
Raw materials	$ 8,635	$ 7,982
Finished goods	4,840	4,096
Total	$ 13,475	$ 12,078

Note 5 - Summary of Warranties

Note 5 - Summary of Warranties (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Beginning Balance	$ 1,819	$ 1,167
Add: Accruals for warranties issued during the period	1,254	816
Less: Settlements made during the period	(1,254)	(780)
Ending Balance	$ 1,819	$ 1,203

Note 6 - Deferred Service Con32

Note 6 - Deferred Service Contract Revenue (Details Textual) - USD ($) $ in Millions	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Deferred Revenue Costs Incurred	$ 1.6	$ 1.7

Note 6 - Summary of Deferred Se

Note 6 - Summary of Deferred Service Contract Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Beginning Balance, deferred service contract revenue	$ 10,469	$ 12,949
Add: Payments received	3,263	2,802
Less: Revenue recognized	(3,220)	(3,223)
Ending Balance, deferred service contract revenue	$ 10,512	$ 12,528

Note 7 - Stockholders' Equity34

Note 7 - Stockholders' Equity, Stock Plans and Stock-based Compensation Expense (Details Textual) - USD ($) $ in Millions		3 Months Ended
		Mar. 31, 2016	Feb. 18, 2016
Modified Stock Buyback Program [Member]
Stock Repurchase Program, Remaining Authorized Repurchase Amount		$ 9.7	$ 10
Stock Repurchased During Period, Shares		28,013
Treasury Stock, Value, Acquired, Cost Method		$ 305,000
Two Thousand Four Equity Incentive Plan [Member] | Fungible Shares [Member]
Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross		416,474
Two Thousand Four Equity Incentive Plan [Member] | Performance Shares [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted		196,450
Two Thousand Four Equity Incentive Plan [Member]
Number of Stock Awards Counted for Every Share Granted or Canceled		2.12
Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross		836,128
Share-based Compensation Arrangement by Share-based Payment Award, Shares Issued in Period		144,312
Employee Stock Option [Member]
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized		$ 6.6
Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition		2 years 18 days
Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross	[1],[2]	836,128
[1]	Included in 'Stock awards granted' of 836,128, was 416,474 fungible shares relating to 196,450 of PSUs granted. These PSUs will result in a higher or lower number of shares of common stock that may be paid out on March 15, 2017, based on the achievement of three performance goals at targets that were pre-determined by the Board and disclosed in a Form 8-K on February 8, 2016.
[2]	The Company has a “fungible share” provision in its 2004 Equity Incentive Plan whereby for each full-value award (RSU/PSU) issued or canceled under the Plan, results in a requirement to subtract / add back 2.12 shares from / to the Shares Available for Grant.

Note 7 - Stock-based Compensati

Note 7 - Stock-based Compensation Expense by Department (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Cost of Sales [Member]
Allocated Share Based Compensation Expense	$ 141	$ 103
Selling and Marketing Expense [Member]
Allocated Share Based Compensation Expense	376	185
Research and Development Expense [Member]
Allocated Share Based Compensation Expense	180	182
General and Administrative Expense [Member]
Allocated Share Based Compensation Expense	635	491
Allocated Share Based Compensation Expense	$ 1,332	$ 961

Note 7 - Activity Under the 200

Note 7 - Activity Under the 2004 Equiy Incentive Plan (Details)	3 Months Ended
	Mar. 31, 2016$ / sharesshares
Balance, shares available for grant (in shares)	1,263,425
Balance, stock options outstanding (in shares)	2,148,797
Balance, weighted-average exercise price (in dollars per share) | $ / shares	$ 9.31
Options granted, shares available for grant (in shares)	(28,000)
Options granted, stock options outstanding (in shares)	28,000
Options granted, weighted-average exercise price (in dollars per share) | $ / shares	$ 11.24
Stock awards granted(1)(2) (in shares)	(836,128)	[1],[2]
Options exercised, stock options outstanding (in shares)	(88,170)
Options exercised, weighted-average exercise price (in dollars per share) | $ / shares	$ 8.44
Options canceled, shares available for grant (in shares)	26,213
Options canceled, stock options outstanding (in shares)	(26,213)
Options canceled, weighted-average exercise price (in dollars per share) | $ / shares	$ 10.21
Stock awards canceled(1) (in shares)	70,278	[2]
Balance, shares available for grant (in shares)	495,788
Balance, stock options outstanding (in shares)	2,062,414
Balance, weighted-average exercise price (in dollars per share) | $ / shares	$ 9.36
[1]	Included in 'Stock awards granted' of 836,128, was 416,474 fungible shares relating to 196,450 of PSUs granted. These PSUs will result in a higher or lower number of shares of common stock that may be paid out on March 15, 2017, based on the achievement of three performance goals at targets that were pre-determined by the Board and disclosed in a Form 8-K on February 8, 2016.
[2]	The Company has a “fungible share” provision in its 2004 Equity Incentive Plan whereby for each full-value award (RSU/PSU) issued or canceled under the Plan, results in a requirement to subtract / add back 2.12 shares from / to the Shares Available for Grant.

Note 8 - Antidilutive Securitie

Note 8 - Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares shares in Thousands	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Employee Stock Option [Member]
Antidilutive Securities (in shares)	3,191	3,164
Restricted Stock Units (RSUs) [Member]
Antidilutive Securities (in shares)	405	318
Performance Shares [Member]
Antidilutive Securities (in shares)	158	62
ESPP [Member]
Antidilutive Securities (in shares)	42	33
Antidilutive Securities (in shares)	3,796	3,577

Note 9 - Income Taxes (Details

Note 9 - Income Taxes (Details Textual) - USD ($)	3 Months Ended
	Mar. 31, 2016	Mar. 31, 2015
Deferred Tax Assets Valuation Allowance Percentage	100.00%	100.00%
Income Tax Expense (Benefit)	$ 24,000	$ 50,000

Note 10 - Commitments and Con39

Note 10 - Commitments and Contingencies (Details Textual) $ in Millions	Feb. 11, 2016USD ($)
Minimum [Member]
Estimated Litigation Liability	$ 10